These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4152712)

  • 21. Acute otitis media: treatment results in relation to bacterial etiology.
    Nilson BW; Poland RL; Thompson RS; Morehead D; Baghdassarian A; Carver DH
    Pediatrics; 1969 Mar; 43(3):351-8. PubMed ID: 4975539
    [No Abstract]   [Full Text] [Related]  

  • 22. [Microbiological studies on 7-acylamido cephalosporanic acid derivativies. 1. Structure of 7-side chain and protective effects against infections].
    Nishida M; Matsubara T; Mine Y; Yokota Y; Takano T
    Jpn J Antibiot; 1969 Apr; 22(2):144-50. PubMed ID: 4389775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Protective effect of placental lysozyme on experimental infections in mice induced by Clostridium tetani, Staphylococcus aureus and Diplococcus pneumoniae].
    Suyama T; Oguro Y; Doi T; Izaka K
    Jpn J Antibiot; 1969 Aug; 22(4):287-98. PubMed ID: 4390930
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of early-onset group B streptococcal disease in infants.
    Kainer M; McCauley T; Craig AS
    Tenn Med; 2005 May; 98(5):232-3. PubMed ID: 15934534
    [No Abstract]   [Full Text] [Related]  

  • 25. [Group A beta-hemolytic streptococcus infection and varicella].
    La Placa G; Andreotti M; Arlati S; Petroni F; Pugliese S
    Minerva Pediatr; 1998 Oct; 50(10):427-31. PubMed ID: 10191885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptococcus pneumoniae: an unusual pathogen in neonatal sepsis of vertical transmission.
    Hermoso Torregrosa C; Carrasco Zalvide M; Ferrer Castillo MT
    Arch Bronconeumol; 2012 Nov; 48(11):425-6. PubMed ID: 22766421
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bacteriological study on clindamycin-2-palmitate (author's transl)].
    Ono H; Otsuki M; Nakazawa S
    Jpn J Antibiot; 1973 Aug; 26(4):321-4. PubMed ID: 4582578
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pseudomonas aeruginosa--a bacteriological ghost].
    Midtvedt T
    Tidsskr Nor Laegeforen; 1969 Feb; 89(3):190. PubMed ID: 4307572
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimicrobial therapy of experimental group B streptococcal infection in mice.
    Deveikis A; Schauf V; Mizen M; Riff L
    Antimicrob Agents Chemother; 1977 May; 11(5):817-20. PubMed ID: 327920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of ampicillin and trimethoprim-sulfamethoxazole in otitis media.
    Cameron GG; Pomahac AC; Johnston MT
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):87-8. PubMed ID: 1093657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical conference: bacterial endocarditis.
    South Med J; 1974 Jan; 67(1):87-96. PubMed ID: 4808997
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tetracycline resistance in beta-hemolytic streptococci and pneumococci].
    Pulverer G
    Dtsch Med Wochenschr; 1967 Sep; 92(36):1608-12. PubMed ID: 4383130
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of Pseudomonas aeruginosa keratitis with tobramycin and gentamicin: animal experiments (author's transl)].
    Behrens-Baumann W; Paul HH; Ansorg R
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):197-9. PubMed ID: 7230715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 35. [Microbiological and pharmacological parameters as evaluation criteria for chemotherapeutics].
    Naumann P
    Adv Clin Pharmacol; 1977; 14():21-34. PubMed ID: 339676
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current Pseudonomas aeruginosa infection and its treatment].
    Konno M
    Nihon Shonika Gakkai Zasshi; 1972 Jan; 76(1):1-2. PubMed ID: 4623366
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental chemotherapy of pseudomonas aeruginosa infections].
    Nakazawa S; Kanamori M; Horita A; Miyoshi T; Mekata I
    Jpn J Antibiot; 1968 Apr; 21(2):84-7. PubMed ID: 4299625
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo activity of amoxicillin and ampicillin against gram-positive bacteria: results of prophylactic studies.
    Grunberg E; Cleeland R; Beskid G; DeLorenzo W
    J Infect Dis; 1978 Dec; 138(6):872-6. PubMed ID: 33219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General principles of antimicrobial therapy.
    Hermans PE
    Mayo Clin Proc; 1977 Oct; 52(10):603-10. PubMed ID: 20538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific therapy of Pseudomonas aeruginosa infection.
    Can Med Assoc J; 1971 Nov; 105(9):898-9. PubMed ID: 5004773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.